| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Competidores de Frequency Therapeutics, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$14.98 |
| 52 Week High | US$279.50 |
| 52 Week Low | US$9.15 |
| Beta | 0.77 |
| 1 Month Change | -0.10% |
| 3 Month Change | -58.68% |
| 1 Year Change | -87.52% |
| 3 Year Change | -98.71% |
| 5 Year Change | n/a |
| Change since IPO | -97.81% |
Noticias y actualizaciones recientes
Recent updates
Is Frequency Therapeutics (NASDAQ:FREQ) Weighed On By Its Debt Load?
Jan 01
Frequency Therapeutics (NASDAQ:FREQ) Has Debt But No Earnings; Should You Worry?
Jan 19Frequency Therapeutics, Inc. (NASDAQ:FREQ) Analysts Are Reducing Their Forecasts For This Year
Aug 18Health Check: How Prudently Does Frequency Therapeutics (NASDAQ:FREQ) Use Debt?
Jul 31Frequency Therapeutics (FREQ) Investor Presentation - Slideshow
Jun 18Frequency Therapeutics: A Look At What's Next After A Disappointing Data Readout
Apr 21Frequency Therapeutics, Inc. (NASDAQ:FREQ) Analysts Are More Bearish Than They Used To Be
Apr 04We're Not Worried About Frequency Therapeutics' (NASDAQ:FREQ) Cash Burn
Mar 15If You Had Bought Frequency Therapeutics (NASDAQ:FREQ) Shares A Year Ago You'd Have Earned 55% Returns
Jan 22Have Insiders Sold Frequency Therapeutics, Inc. (NASDAQ:FREQ) Shares Recently?
Dec 27Frequency Therapeutics to host investor event in early January next year
Dec 18How Much Are Frequency Therapeutics, Inc. (NASDAQ:FREQ) Insiders Taking Off The Table?
Dec 10Frequency Therapeutics, Inc. (NASDAQ:FREQ) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 19Frequency Therapeutics EPS beats by $0.16, beats on revenue
Nov 16Frequency Therapeutics Is An Interesting Speculative Play Ahead Of Phase 2 Results
Nov 09Rentabilidad de los accionistas
| FREQ | US Biotechs | Mercado US | |
|---|---|---|---|
| 7D | 29.1% | 0.1% | 2.2% |
| 1Y | -87.5% | -1.0% | 22.8% |
Rentabilidad vs. Industria: FREQ obtuvo unos resultados inferiores a los del sector US Biotechs , que el año pasado arrojó un rendimiento del -3.7%.
Rentabilidad vs. Mercado: FREQ obtuvo unos resultados inferiores a los del mercado US, que fue del 19.3% el año pasado.
Volatilidad de los precios
| FREQ volatility | |
|---|---|
| FREQ Average Weekly Movement | 12.5% |
| Biotechs Industry Average Movement | 11.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: El precio de las acciones de FREQ ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de FREQ ha disminuido de 21% a 12% en el último año, pero sigue siendo superior al 75% de los valores de US.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2014 | 47 | David Lucchino | www.frequencytx.com |
Resumen de fundamentos de Frequency Therapeutics, Inc.
| Estadísticas fundamentales de FREQ | |
|---|---|
| Capitalización bursátil | US$547.27m |
| Beneficios(TTM) | -US$59.31m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)-9.2x
Ratio precio-beneficio (PE)¿Está FREQ sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de FREQ | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$42.02m |
| Beneficio bruto | -US$42.01m |
| Otros gastos | US$17.30m |
| Beneficios | -US$59.31m |
Últimos beneficios comunicados
Sep 30, 2023
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -1.62 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado FREQ a largo plazo?
Ver rendimiento histórico y comparativa